06/07/2012
Their work establishes the ATX/LPA axis as a novel player in chronic inflammatory disorders [Pubmed3] and as a promising therapeutic target. See also related highlights at Nat. Rev. Rheum, Nat. lipid maps, F1000, AJRCMB and TIS.
Highlights
